Literature DB >> 28008199

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement.

Tomohiro Komada1, Kojiro Suzuki1, Hiroaki Ishiguchi1, Hisashi Kawai1, Takahiro Okumura2, Akihiro Hirashiki2, Shinji Naganawa1.   

Abstract

Cardiac sarcoidosis (CS) can cause sudden death, which is the leading cause of mortality in patients with sarcoidosis in Japan. However, it is difficult to diagnose CS because of the lack of a sensitive diagnostic method for the condition. Late gadolinium-enhanced cardiac magnetic resonance (MR) imaging demonstrates improved sensitivity for diagnosing CS. Therefore, it is important to know the late gadolinium-enhancement (LGE) characteristics of CS on cardiac MR images in order to diagnose CS accurately. In this study, we investigated the most common sites of LGE on cardiac MR images in CS. Late gadolinium-enhanced MR images of 9 consecutive patients with CS (obtained between August 2009 and July 2015) were reviewed by two radiologists. The distribution of LGE was evaluated using the American Heart Association 17-segment model of the left ventricle. The LGE in each segment was also classified into 4 patterns according to the myocardial layer in which it occurred (the subepicardial, subendocardial, intramural, and transmural layer patterns). All 9 patients exhibited LGE in their left ventricle, and 70 of 153 (46%) myocardial segments were enhanced. All of the patients displayed LGE in the basal septal wall. The patients' LGE layer patterns were as follows: subepicardial: 40% (28/70), intramural: 30% (21/70), subendocardial: 16% (11/70), and transmural: 14% (10/70). The basal septum wall and subepicardial layer often exhibit LGE on cardiac MR images in CS patients. LGE can be observed in other segments and layers in some cases.

Entities:  

Keywords:  SPIR; cardiac sarcoidosis; late gadolinium enhancement; magnetic resonance imaging

Year:  2016        PMID: 28008199      PMCID: PMC5159469          DOI: 10.18999/nagjms.78.4.437

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  26 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis.

Authors:  Kenji Yodogawa; Yoshihiko Seino; Reiko Shiomura; Kenta Takahashi; Ippei Tsuboi; Shunsuke Uetake; Hiroshi Hayashi; Tsutomu Horie; Yu-Ki Iwasaki; Meiso Hayashi; Yasushi Miyauchi; Wataru Shimizu
Journal:  J Cardiol       Date:  2013-09-06       Impact factor: 3.159

Review 3.  Myocardial sarcoidosis.

Authors:  O P Sharma; A Maheshwari; K Thaker
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

4.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Authors:  Shinji Ishimaru; Ichizo Tsujino; Toshiki Takei; Eriko Tsukamoto; Shinji Sakaue; Mitsunori Kamigaki; Naofumi Ito; Hiroshi Ohira; Daisuke Ikeda; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur Heart J       Date:  2005-04-04       Impact factor: 29.983

5.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

Authors:  A Uemura; S Morimoto; S Hiramitsu; Y Kato; T Ito; H Hishida
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.

Authors:  Peter Kellman; Andrew E Arai; Elliot R McVeigh; Anthony H Aletras
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

8.  The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.

Authors:  Fumitaka Matoh; Hiroshi Satoh; Katsunori Shiraki; Keiichi Odagiri; Takeji Saitoh; Tsuyoshi Urushida; Hideki Katoh; Yasuo Takehara; Harumi Sakahara; Hideharu Hayashi
Journal:  J Cardiol       Date:  2008-04-24       Impact factor: 3.159

9.  Clinicopathological study of fatal myocardial sarcoidosis.

Authors:  Y Matsui; K Iwai; T Tachibana; T Fruie; N Shigematsu; T Izumi; A H Homma; R Mikami; O Hongo; Y Hiraga; M Yamamoto
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

10.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

View more
  5 in total

1.  Clinics in diagnostic imaging (189). Acute phase cardiac sarcoidosis (CS).

Authors:  Sumer Nrupendra Shikhare; Ashish Chawla; Ree Nee Khoo; Wilfred Cg Peh
Journal:  Singapore Med J       Date:  2018-08       Impact factor: 1.858

Review 2.  Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.

Authors:  Tong Liu; Deli Song; Jianzeng Dong; Pinghui Zhu; Jie Liu; Wei Liu; Xiaohai Ma; Lei Zhao; Shukuan Ling
Journal:  Front Physiol       Date:  2017-04-24       Impact factor: 4.566

3.  Cardiac Sarcoidosis: A Unique Presentation.

Authors:  Mihir Odak; Kameron Tavakolian; Steven Douedi; Ndausung Udongwo; Islam Elkherpitawy; Hani Douedi; Natasha Campbell
Journal:  Cureus       Date:  2022-07-26

Review 4.  Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments.

Authors:  Rashi Jain; Dhananjay Yadav; Nidhi Puranik; Randeep Guleria; Jun-O Jin
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

Review 5.  The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis.

Authors:  Marijana Tadic; Cesare Cuspidi; Sahrai Saeed; Bogomir Milojevic; Isidora Grozdic Milojevic
Journal:  Heart Fail Rev       Date:  2020-10-06       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.